Abstract
Introduction
Information on survival patterns of transfusion recipients is essential for the continued assessment of transfusion-transmitted diseases and thus to the implementation of new and often expensive screening techniques [1] [2] [3] [4] . However, long-term survival of transfusion recipients has only been sparsely studied and accordingly remains poorly characterized. The largest study to date reported cumulative survival estimates and crude mortality rates for 6,779 recipients in the period up to five years after the transfusion event 5 . To our knowledge, information on longer follow-up, seven and ten years, is available only from two smaller cohorts of 932 and 802 transfusion recipients, respectively 6, 7 . The need for precise information is emphasized by suggested secular trends in recipient survival 6, 7 and by the realization that some transfusion-related complications possibly become manifest only decades after the transfusion event, e.g. variant Creutzfelt Jacob's disease 8 .
In the absence of reliable or sufficiently detailed survival data, estimates of cost-effectiveness of proposed screening techniques often rely on crude assumptions about transfused patients' mortality, e.g. a constant mortality probability more than three years after transfusion 9 or a mortality that would resemble that of the general population five years after transfusion 10 . While the underlying conditions necessitating blood transfusion in the recipient make this latter assumption unlikely, comparisons of transfusion recipients' mortality rates with those prevailing in the general population are scarcely available in the literature, neither overall nor with respect to specific causes 8, 11 .
We assessed both absolute and relative mortality after transfusion using a Danish-Swedish population-based register encompassing more than 1.1 million transfusion recipients that were followed for up to 20 years after their first recorded blood transfusion.
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Material
In Sweden and Denmark blood banks are part of the hospitals they serve, and thus they are a part of the public health care sector. Blood banks register the identity of all blood donors, all blood donations and all blood components issued to patients, as well as the identity of all recipients. In both 15, 16 . Also as part of the SCANDAT project, information about hospitalizations, including department and primary and secondary discharge diagnoses, coded according to the International Classification of Diseases (ICD) 17 , versions 6 through 10, and surgical and other procedures, were obtained for all individuals in the database through linking with the Danish and Swedish nationwide hospital discharge registers 18, 19 . The creation of the SCANDAT database and the conduct of the present study were approved by appropriate scientific ethical committees and data protection agencies in both countries.
Mortality data for the general Danish and Swedish populations according to country, sex, age and calendar period was obtained from the World Health Organization 20 .
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Methods
Follow-up
For technical reasons relating to the initiation of computerization and to optimize comparability between Denmark and Sweden, information on recipients whose first transfusion was prior to 1 January 1983 was disregarded in both countries. Follow-up of the recipients started on the day of the first registered transfusion of any blood component and ended on the day of death, emigration or 31
December 2002, whichever came first. In the present study, a blood transfusion was defined as 
Statistical analyses
Cumulative survival according to time since first transfusion was estimated by Kaplan-Meier methodology using the LIFETEST procedure in SAS v. 9.1 22 . Cumulative survival was estimated overall for the entire cohort of transfusion recipients and stratified by country, sex, age at first transfusion relative mortality assessed as incidence rate ratios were estimated by log-linear Poisson regression and associated 95% confidence limits.
We also estimated the recipients' risk of dying relative to the risk in the general Danish and Swedish populations. Specifically, the relative risk of dying was expressed as the standardized mortality ratio (SMR), where the observed number of deaths is compared to the number expected based on mortality rates in the general populations in strata defined by country, sex, 5-year age-group, and one-year calendar period. Population data were available for ages 0 to 90 years for the calendar pe- 
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Results
Transfusion recipients
A total of 1,118,261 transfusion recipients was identified, and these received a total of 9,979,082 units during 2,172,917 transfusion episodes. Seventy two percent of all transfused components were RBCs, 19% were FFP, 7% were platelets and the remaining 2% were other components including whole blood. The first registered transfusion was autologous for 5,588 (0.5%) recipients and the donor was unknown for 60,028 (5.4%) recipients. Table 1 shows characteristics of transfusion recipients according to country and covariates. The majority of transfusion recipients (69.0%) lived in Sweden, reflecting the earlier introduction of computerized blood bank systems and a larger population. In both countries more women than men were transfused.
Median age at first transfusion was 69. The distribution of transfusion recipients according to calendar period at first transfusion differed between Denmark and Sweden, reflecting the introduction of computerized blood bank systems at different times. In the total cohort, 73.1% of recipients had a transfusion registered for the first time during the period 1993-2002. The majority of recipients were transfused for the first time while admitted to surgical departments, followed by departments of internal medicine, with the difference being more pronounced in Sweden (Table 1) .
Cumulative survival
Cumulative survival by time since first transfusion stratified by covariates is shown in sex, country, department of first transfusion and cumulative number of units received, there were no significant differences between the different calendar periods (data not shown).
Relative mortality
The standardized mortality ratio (SMR) of transfusion recipients relative to the general population by time after first transfusion and covariates are shown in Table 3 . Overall, the standardized mortality ratio was 17.6 (95% CI 17.5-17.7) times higher in the transfused cohort during the first three months after first transfusion, meaning that during the first three months after first transfusion recipients had a 17.6 times higher risk of dying compared with a person in the general population with similar demographic characteristics i.e. from the same country, of same age and sex and during the same calendar period. The SMR was 2.1 (95% CI 2.1-2.1) in the period from 1 to 4 years after first transfusion, and even 15-17 years after first transfusion a statistically significantly increased SMR of 1.3 (95% CI 1.2-1.4) persisted. The relative mortality of transfusion recipients was slightly higher in Denmark than in Sweden for the first ten years after first transfusion, and slightly higher for men than for women.
Irrespective of the type of department at which the first transfusion was given, the relative risk of dying was the highest shortly after transfusion. With continued follow-up patients transfused at departments of internal medicine continued to have the highest relative risk of dying, whereas women transfused at departments of gynecology and obstetrics had only a slightly increased risk of dying 10 years or more after the transfusion event. Increasing number of units received during the first month after first transfusion was associated with increasing mortality relative to the general population. While being most pronounced shortly after first transfusion, this was true at all times since first transfusion. Cause-of-death-specific SMRs showed that the increased relative mortality applied to all causes of death, and were highest for digestive, neoplastic, and infectious diseases. Figure 3 shows SMRs according to time since first transfusion for different age groups. During the first years following a transfusion, the SMR was markedly increased for all age groups, though most for the youngest age groups. Even after more than 15 years of follow-up an excess 10/21 mortality was observed in transfusion recipients; the younger the recipient was at time of first transfusion the higher the persistent excess mortality.
As illustrated in Figure 4 , the decrease in excess SMR of transfusion recipients following a transfusion was comparable in recipients transfused in different calendar periods. Assuming the mortality pattern in transfusion recipients five years post transfusion is similar to that of the general population, we underestimated the number of deaths by 33%.
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Discussion
In the present study we took advantage of information about more than 1.1 million transfusion recipients registered in databases in Swedish and Danish blood banks in the calendar period between 1983 and 2002. Combined with data from nationwide population and cause-of-death registers, we were able to characterize patterns of both absolute and relative survival after transfusion with unprecedented precision.
Although practically and ethically challenging to study, it has been suggested that blood transfusion in itself may increase the risk of death in critically ill patients 23 . While the design of our study did not allow us to investigate this, we believe that the poor survival following blood transfusion demonstrated in the present study reflects that transfusions are given to patients who already are at increased risk of dying from e.g. trauma, major operations or serious illness.
Consistent with previous studies, absolute mortality was high in the period shortly after blood transfusion. The excess relative mortality among transfusion recipients was not restricted to the period shortly after first transfusion, but was apparent even 17 years after first transfusion. As in previous studies, determinants of a decreased absolute survival included male sex, and old age [6] [7] [8] 11, 24 .
Although survival is also lower in men than in women in the general population, the relative measure of mortality revealed that the excess mortality among transfusion recipients was more pronounced in men than in women. Despite decreasing absolute survival with increasing age, mortality among transfusion recipients relative to the general population was highest in the youngest age group. As also suggested in earlier surveys [5] [6] [7] [8] 11, 24 , the absolute survival of transfusion recipients decreased in more recent calendar periods. This is likely to in part reflect the increasing age of the recipients since we observed no differences between different calendar periods after adjusting for age, sex and country. Accordingly, we found no indication that survival among transfusion recipients decreased in more recent periods.
In addition to old age, male sex, and recent calendar period transfusion recipients' mortality was also influenced by the condition necessitating blood transfusion and by the number of units re-
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ceived. Using department at first transfusion as a crude proxy measure of indication, patients admitted to departments of internal medicine had the highest mortality, both absolute and relative to the general population. Similarly, patients receiving most transfusions were at highest risk of dying. On both absolute and relative scales, the lowest mortality was observed among women receiving transfusions at obstetrical and gynecological departments. Absolute mortality was high due to cardiovascular and neoplastic diseases and low due to infectious, respiratory and digestive diseases. However, relative to the general population mortality due to infectious and digestive diseases was markedly elevated in transfusion recipients. As expected, relative mortality was also markedly increased for neoplastic diseases. This observed variation in absolute mortality is consistent with previous findings [6] [7] [8] 11, 24 .
A higher absolute mortality in Denmark compared with Sweden is a general phenomenon, not limited to transfusion recipients. Generally, the higher absolute mortality in Denmark is ascribed to a higher level of tobacco smoking and alcohol consumption 25 . SMRs stratified by country showed marginally lower SMRs in Swedish recipients than in Danish recipients. This difference is not readily explained, but presumably is not related to more strict transfusion criteria in Denmark, as more transfusions are administered in Denmark than in Sweden relative to the population size 12 . Adjusted analyses revealed that the higher mortality in Denmark could not be attributed to differences in calendar period, age, sex, department of first transfusion or cumulative number of units received.
Absolute survival estimates more than 10 years after first blood transfusion have not previously been available, nor have comparisons with expected mortality to any greater extent 8, 11 . The most important finding presented in this regard is the substantial long-term survival indicating that even transfusion-transmitted diseases with very long incubation periods can potentially affect a considerable number of individuals 26 . Overall, our analyses also revealed that the recipients continued to have a 30% increased mortality relative to the general population 15-17 years after first transfusion.
On the other hand, transfusion-transmitted infectious agents would accumulate in patients receiving 13/21 multiple transfusions and the long-term survival of these patients is as shown in the present analyses markedly lower than other recipients' survival. Accordingly, both estimates of long-term survival of transfusion recipients and the uneven distribution by number of transfused units should ideally be factored in future policy decisions and cost-effectiveness calculations.
A number of factors related to blood transfusion therapy vary both between and within countries and over time 27 . This includes blood product manufacturing procedures, treatment regimes, private/public health care system, and blood transfusion policies. Even within countries, different indications for transfusion likely exist in different hospitals for the same patient categories 28 . Furthermore, transfusion criteria have likely changed over time in individual hospitals, e.g. as a result of the Human Immunodeficiency Virus (HIV) epidemic. Accordingly, the higher age of recipients transfused in later calendar periods in our study may reflect more strict transfusion criteria after the onset of the HIV epidemic and/or more aggressive treatment even in elderly patients. Our findings therefore highlight the need for caution in making direct comparisons of absolute survival between studies.
Our population-based cohort was very large, as it comprised all transfusion recipients in Denmark and Sweden from 1 January 1983 for whom computerized transfusion records existed. Because of the continuously updated civil registration systems in both countries, there was virtually no loss to follow-up. However, nationwide or near nationwide coverage was not achieved until the late 1990's in the two countries. It is possible therefore, that some recipients, especially in the older age groups,
were transfused prior to inclusion in the current cohort and thus have had a longer survival than we have estimated. We could, on the other hand, also have missed some transfusion recipients altogether if they had died before inclusion, and this would result in an increased proportion of "survivors" in the early cohort. The differences in the Danish and Swedish part of the data regarding the distribution of departments of first transfusion are also affected by the gradually increasing national 14/21 coverage in the two countries. Transfusion of whole blood was administered in Denmark and Sweden until the beginning of the 1980s, at which time blood component therapy was introduced.
We had access to detailed mortality rates for the general populations, and could therefore produce standardized mortality ratios in addition to absolute survival estimates. In theory, our estimates would be biased towards unity, i.e. be conservative, as the available background mortality rates are based on the total population, which includes deaths in transfusion recipients. Finally, it must be emphasized that no analyses were performed of the indication for transfusion, and that we did not intend to study the possible effects of blood transfusion itself on survival. Had the scope of our study been etiologic rather than descriptive, a group of patients with similar characteristics who did not receive transfusion would be a more suitable group for comparison than the general population.
In conclusion, our study contributes new information on both short and long-term survival of transfusion recipients. Our results provide information to improve assessments of the consequences of possible transfusion-transmitted disease, as well as estimates of cost-benefit of new screening techniques. Furthermore, our work emphasises that any comparisons of survival of recipients between studies requires in-depth knowledge of the composition of the transfusion recipient cohorts. Table 3 . Standardized mortality ratio (SMR) of transfusion recipients relative to the general population, according to time since first transfusion and covariates.
*Cumulative number of units received during the first month after first transfusion estimated as a 
time-varying covariate ------------------------Time since first transfusion ------------------------
